跳至主要内容
临床试验/NCT01847703
NCT01847703已完成不适用

Randomized Trial Comparing Robotic and Abdominal Surgery for High Risk Endometrial Cancer

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2013年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
2
主要终点
Number of harvested lymph nodes

研究概览

简要总结

This study is intended to explore differences in oncologic and surgical safety between robotic assisted laparoscopy and conventional abdominal surgery for high risk endometrial cancer.

详细描述

Hypothesis

Robotic assisted laparoscopy (RAL)is equal in terms of oncologic and surgical safety as conventional abdominal surgery (AS) for high risk endometrial cancer (EC).

Methods: Women with high risk EC (defined as high grade endometrial, clear cell or serous) are randomized to either RAL or AS. Both groups will undergo complete surgical staging (hysterectomy, bilateral salpingoophorectomy, pelvic and paraaortal lymphadenectomy)

Primary endpoint: Number of harvested lymph nodes per station Secondary endpoints: Recurrences up to 3 year after surgery. Lymphatic side-effects, quality of life, cost, surgical morbidity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-75 years of age
  • High risk endometrial cancer

排除标准

  • WHO performance>1
  • Severe comorbidity, ASA>3
  • Unable to understand information

研究组 & 干预措施

Robotic surgery

Experimental

Experimental method, to be compared with standard care

干预措施: Robotic surgery (Procedure)

Abdominal surgery

Active Comparator

Conventional open surgery (laparotomy)

干预措施: Abdominal surgery (Procedure)

结局指标

主要结局

Number of harvested lymph nodes

时间窗: 2 years

Extracted lymphatic tissue from 3 stations (above inferior mesenteric artery, below inferior mesenteric artery, pelvic) is analysed by a pathologist and the number of nodes for each station recorded and compared between the two groups

次要结局

  • Lymphatic side-effects(2 years)
  • Quality of life(2 years)
  • Healthcare cost(2 years)
  • Recurrence of cancer(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Henrik Falconer

MD, PhD

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验